ly 353381 has been researched along with cyclin d1 in 2 studies
| Studies (ly 353381) | Trials (ly 353381) | Recent Studies (post-2010) (ly 353381) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 70 | 12 | 15 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| A'Hern, R; Detre, S; Dowsett, M; Johnston, SR; Riddler, S; Salter, J | 1 |
| Jalink, K; Mancini, MA; Michalides, R; Neefjes, J; Rondaij, M; Sharp, ZD; Zwart, W | 1 |
2 other study(ies) available for ly 353381 and cyclin d1
| Article | Year |
|---|---|
Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft model.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Female; Humans; Mice; Mice, Nude; Piperidines; Protein Biosynthesis; Proteins; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Trefoil Factor-1; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2003 |
Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Resistance; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fluorescence Resonance Energy Transfer; Gene Expression Regulation; HeLa Cells; Humans; Microscopy, Confocal; Models, Chemical; Piperidines; Thiophenes | 2009 |